← Back to Clinical Trials
Recruiting NCT06452966

NCT06452966 The Impact and Effect of Traditional Chinese Medicine Treatment on Organ Failure in Critically Ill Patients

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT06452966
Status Recruiting
Phase
Sponsor China Medical University Hospital
Condition Organ Failure, Multiple
Study Type INTERVENTIONAL
Enrollment 350 participants
Start Date 2024-05-07
Primary Completion 2026-12-30

Trial Parameters

Condition Organ Failure, Multiple
Sponsor China Medical University Hospital
Study Type INTERVENTIONAL
Phase N/A
Enrollment 350
Sex ALL
Min Age 20 Years
Max Age N/A
Start Date 2024-05-07
Completion 2026-12-30
Interventions
traditional Chinese medicineRoutine ICU carehistorical Routine ICU care

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

Brief Summary

Critically ill patients are at risk of or suffering from one or more key organs or organ system failure. This study will measure the effect of traditional Chinese medicine(TCM) interventions on critically ill patients admitted to the intensive care unit (ICU). The goal of this clinical trial is to learn if traditional Chinese medicine(TCM) is effective for prevention and treatment of organ failure in ICU patients. Patients in this group will receive intervention for 2 weeks. A multi-center non-randomized real word data study, will include 3 groups: intervention group (TCM)(n=70), control group and historical control group (admitted to the same ICU in the period of 01.2019 to 12.2023). Main outcomes include sequential organ failure assessment (SOFA) score, ICU length of stay, hospital length of stay, number of days of respirator uses and western medicine medication used study follow up will be 2 weeks.

Eligibility Criteria

Inclusion Criteria: * Age 20 and above * Surgical ICU patients * The use of Chinese medicine must be approved by the attending physician in the surgical intensive care unit Exclusion criteria: * Patients' family members refuse TCM intervention

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology